We hypothesize that increased levels of LINC00654 in DLBCL result in elevated expression of the NINL gene, which negatively regulates cuproptosis through modulation of cell cycle changes, thus promoting the progression of DLBCL. The gene discussed is LINC00654; the disease is diffuse large B-cell lymphoma.